These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18830058)

  • 1. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
    Nilforoushzadeh MA; Sadeghian G; Jaffary F; Ziaei H; Shirani-Bidabad L; Mahzoni P
    Korean J Parasitol; 2008 Sep; 46(3):175-7. PubMed ID: 18830058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lesion improvement in lupoid leishmaniasis patients with two treatment approaches: trichloroacetic Acid and intralesional meglumine antimoniate.
    Banihashemi M; Yazdanpanah MJ; Amirsolymani H; Yousefzadeh H
    J Cutan Med Surg; 2015; 19(1):35-9. PubMed ID: 25775661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.
    Layegh P; Rahsepar S; Rahsepar AA
    Am J Trop Med Hyg; 2011 Apr; 84(4):539-42. PubMed ID: 21460006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
    Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
    J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous leishmaniasis "chiclero's ulcer" in subtropical Ecuador.
    Calvopiña M; Martinez L; Hashiguchi Y
    Am J Trop Med Hyg; 2013 Aug; 89(2):195-196. PubMed ID: 23926136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco].
    Hjira N; Frikh R; Marcil T; Lamsyah H; Oumakhir S; Baba N; Boui M
    Pan Afr Med J; 2014; 17():272. PubMed ID: 25309671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
    Perez-Franco JE; Cruz-Barrera ML; Robayo ML; Lopez MC; Daza CD; Bedoya A; Mariño ML; Saavedra CH; Echeverry MC
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Alavi A
    Int J Dermatol; 2002 Aug; 41(8):521-4. PubMed ID: 12207774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate.
    Momeni AZ; Aminjavaheri M
    Int J Dermatol; 2000 Nov; 39(11):880. PubMed ID: 11123462
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
    Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ; Reiszadae MR; Aminjavaheri M
    Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
    Noguera-Morel L; Azorin D; Xirotagaros G
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran.
    Mashayekhi Goyonlo V; Derakhshan Z; Darchini-Maragheh E
    Am J Trop Med Hyg; 2023 Jun; 108(6):1164-1166. PubMed ID: 37094789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran.
    Abdellahi L; Hejazi SH; Amirmozafari N; Sotoodehnejadnematalahi F
    Arch Iran Med; 2020 Nov; 23(11):740-748. PubMed ID: 33220690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.